0001493152-17-011992.txt : 20171024
0001493152-17-011992.hdr.sgml : 20171024
20171024165040
ACCESSION NUMBER: 0001493152-17-011992
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171017
FILED AS OF DATE: 20171024
DATE AS OF CHANGE: 20171024
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gormally John J
CENTRAL INDEX KEY: 0001661118
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36268
FILM NUMBER: 171151404
MAIL ADDRESS:
STREET 1: 80 WALSH DRIVE
CITY: MAHWAH
STATE: NJ
ZIP: 07430
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akers Biosciences, Inc.
CENTRAL INDEX KEY: 0001321834
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 GROVE RD
CITY: THOROFARE
STATE: NJ
ZIP: 08086
BUSINESS PHONE: 856-848-8698
MAIL ADDRESS:
STREET 1: 201 GROVE RD
CITY: THOROFARE
STATE: NJ
ZIP: 08086
FORMER COMPANY:
FORMER CONFORMED NAME: Akers Biosciences Inc
DATE OF NAME CHANGE: 20050325
4
1
form-4.xml
X0306
4
2017-10-17
0
0001321834
Akers Biosciences, Inc.
AKER
0001661118
Gormally John J
80 WALSH DRIVE
MAHWAH
NJ
07430
1
1
0
0
Chief Executive Officer
Common Stock
2017-10-17
4
G
0
150000
0.88
A
180000
D
On October 17, 2017, the Board of Directors of Akers Biosciences, Inc. approved the issuance of 150,000 restricted shares of common stock to the reporting person pursuant to the Akers Biosciences, Inc. 2017 Equity Incentive Plan.
/s/ John J. Gormally
2017-10-24